Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05579847 · ClinicalTrials.gov registry record
Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy
A clinical trial, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- 20
- Enrollment target
NCT05579847: Completed study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT05579847 is a clinical trial that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05579847 has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of the study is to test and understand acceptability and preliminary effectiveness of a mobile educational app specifically customized to patients with advanced Renal Cell Carcinoma (RCC) receiving therapy with combination immunotherapy.
Primary Outcome
Patient's acceptability of the smart phone application for education will be captured in the patient post education survey.
Interventions
- OTHER mHealth Smart Phone Application
- BEHAVIORAL eHEALS digital literacy test
- BEHAVIORAL Weekly Quiz
- BEHAVIORAL European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire
- BEHAVIORAL Patient Post Intervention Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-10-19 |
| Est. Completion | 2024-11-04 |
What the finished NCT05579847 record still lists
NCT05579847 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 5 interventions - of which mHealth Smart Phone Application is the first listed.
NCT05579847 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05579847 about?
NCT05579847 is a clinical study titled "Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy". The purpose of the study is to test and understand acceptability and preliminary effectiveness of a mobile educational app specifically customized to patients with advanced Renal Cell Carcinoma (RCC) receiving therapy with combination immunotherapy.
What is the current status of trial NCT05579847?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2022-10-19. Estimated completion is 2024-11-04.
What interventions are being tested in trial NCT05579847?
The interventions under investigation include: mHealth Smart Phone Application (OTHER), eHEALS digital literacy test (BEHAVIORAL), Weekly Quiz (BEHAVIORAL), European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (BEHAVIORAL), Patient Post Intervention Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT05579847?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI